FDA Drug Recalls

Recalls / Class II

Class IID-1219-2016

Product

METHYL B12 10MG/ML W/PRES (BENZALKONIUM 0.01%) IN NACL 0.9%, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY

Affected lot / code info
a) Lot #: 160201-11, BUD: 07/11/16; Lot #: 160215-13, BUD: 07/11/16; Lot #: 160309-4, BUD: 07/11/16. b) Lot #: 160315-1, BUD: 07/11/16; Lot #: 160201-11, BUD: 07/11/16; Lot #: 160210-71, BUD: 07/11/16; Lot #: 160309-4, BUD: 07/11/16. c) Lot #: 160125-17, BUD: 07/11/16; Lot #: 160210-35, BUD: 07/11/16; Lot #: 160222-20, BUD: 07/11/16; Lot #: 160204-46, BUD: 07/11/16; Lot #: 160307-25, BUD: 07/11/16.

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Medaus, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6801 Cahaba Valley Rd Ste 116, Birmingham, Alabama 35242-9609

Distribution

Quantity
331 mL in Vials
Distribution pattern
U.S. Nationwide, Japan, and New Zealand.

Timeline

Recall initiated
2016-05-13
FDA classified
2016-07-08
Posted by FDA
2016-07-20
Terminated
2017-06-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1219-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.